Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-30

Clinical Trial Update: Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of an oral sumatriptan plus promethazine combination for migraine; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan (Sumatriptan)
  • promethazine (promethazine)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Migraine With Aura, Migraine Without Aura | Phase 3 | Status: COMPLETED